Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
57
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report

Dragana Jovanovic1 Faculty of Medicine, University of Belgrade, Belgrade, Serbia;2 University Hospital of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia
,
Ruza Stevic1 Faculty of Medicine, University of Belgrade, Belgrade, Serbia;2 University Hospital of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia
,
Marta Velinovic2 University Hospital of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia
,
Milica Kontic1 Faculty of Medicine, University of Belgrade, Belgrade, Serbia;2 University Hospital of Pulmonology, Clinical Center of Serbia, Belgrade, SerbiaCorrespondence[email protected]
,
Dragana Maric1 Faculty of Medicine, University of Belgrade, Belgrade, Serbia;2 University Hospital of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia
,
Jelena Spasic3 Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
&
Davorin Radosavljevic3 Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
 show all
Pages 4347-4354 | Published online: 06 Sep 2017

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Soon Hin How, Chong Kin Liam, Muhammad Adil Zainal Abidin, Harissa H Hasbullah, Lye Mun Tho, Gwo Fuang Ho, Ibtisam Muhamad Nor, Yong Kek Pang, Kean Fatt Ho, Muthukkumaran Thiagarajan, Roziana Ariffin, Azlina Samsudin, Azza Omar, Sin Nee Tan, Choo Khoon Ong, Sing Yang Soon & Mau Ern Poh. (2022) Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia. Cancer Management and Research 14, pages 1995-2005.
Read now

Articles from other publishers (2)

Yen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, Po-Lan Su, Chun-Liang Lai, Huang-Chih Chang, Te-Chun Hsia, Sheng-Hao Lin, Kuan-Li Wu, Cheng-Ta Yang, Wu-Chou Su, Yi-Chun Chu, Chin-Chou Wang, Wei-Yu Liao, Yen-Ting Lin, Ching-Hsiung Lin, Meng-Chih Lin, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Mei-Hsuan Lee, Sung-Liang Yu, Chao-Chi Ho & Gee-Chen Chang. (2021) The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study. Therapeutic Advances in Medical Oncology 13, pages 175883592110180.
Crossref
Yumie Yamanaka, Yoshitaka Seki, Takeo Ishikawa & Kazuyoshi Kuwano. (2019) Long-lasting response to afatinib that persisted after treatment discontinuation in a case of EGFR -mutated lung adenocarcinoma . BMJ Case Reports 12:1, pages e227383.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.